NeuroPace Inc
corporate_fare Company Profile
NeuroPace Inc (NASDAQ:NPCE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for NPCE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for NPCE spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- NeuroPace Halves as Guidance Cut and Q3 Revenue Miss Hit Largest Accounts
- NeuroPace 10-Q Backs Q3 Results; Cash $49.2M vs $59.2M Debt, Covenants Intact
- NeuroPace Slashes FY26 Revenue Outlook to $91-92M as Q3 Sales Fall 1.1%
- NeuroPace Q2 Revenue Jumps 17% to $22.8M, Loss Narrows; Cash Runway Solid
- NeuroPace Beats Q2 Revenue, Raises 2026 Guidance on RNS Adoption
Financial Snapshot
Short Interest & Short Volume
8.48 days to coverFINRA reported short interest of 858,343 shares in NPCE as of the October 30, 2026 settlement, a 3.1% decrease from the prior period — about 8.5 days to cover at its recent average daily volume. On November 20, 2026, 50.9% of NPCE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.